Projects funded by the NCN
Effect of SSR 504734, a selective glycine transporter type 1 inhibitor, on seizure activity and therapeutic efficacy of selected antiseizure drugs
2021/41/B/NZ7/00328
Keywords:
glycine transporter type 1 seizures epilepsy epileptogenesis antiseizure drugs
Descriptors:
- NZ7_014:
- NZ3_007:
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Marii Curie-Skłodowskiej w Lublinie, Wydział Biologii i Biotechnologii
woj. lubelskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 8
Call: OPUS 21 - announced on 2021-03-15
Amount awarded: 1 084 400 PLN
Project start date (Y-m-d): 2022-02-04
Project end date (Y-m-d): 2026-02-03
Project duration:: 48 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.
Information in the final report
Publications will be made available after the final report has been accepted.